Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $6.00M | $3.55M | $7.95M |
| Revenue growth | — | — | — | -40.8% | 123.6% |
| Operating income | -$4.87M | -$9.81M | -$7.90M | -$17.2M | -$22.6M |
| Operating margin | — | — | -131.7% | -485.4% | -283.9% |
| Net income | -$4.89M | -$12.2M | -$7.99M | -$14.9M | -$21.2M |
| Net margin | — | — | -133.1% | -418.7% | -267.1% |
| EPS (diluted) | -$1.89 | -$4.73 | -$0.79 | -$0.98 | -$1.27 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$3.90M | -$7.24M | -$11.2M | -$10.3M | -$10.7M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $4.34M | $5.93M | $32.6M | $38.3M | $46.8M |
| Total assets | $4.79M | $8.40M | $41.3M | $44.3M | $50.0M |
| Total liabilities | $1.15M | $16.8M | $5.63M | $4.77M | $6.92M |
| Shareholders' equity | $3.64M | -$8.39M | $35.6M | $39.6M | $43.0M |
| Retained earnings | -$5.62M | -$17.9M | -$25.9M | -$40.7M | -$62.0M |
| Shares (wtd avg diluted) | 2.59M | 2.59M | 10.2M | 15.2M | 16.7M |
Every figure is extracted from Coya Therapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.